Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Perceptions of HPV and cervical cancer among Haitian immigrant women: implications for vaccine acceptability.

Kobetz E, Menard J, Hazan G, Koru-Sengul T, Joseph T, Nissan J, Barton B, Blanco J, Kornfeld J.

Educ Health (Abingdon). 2011 Dec;24(3):479. Epub 2011 Dec 7.

PMID:
22267344
2.

Barriers to human papillomavirus vaccine acceptability in Israel.

Fisher WA, Laniado H, Shoval H, Hakim M, Bornstein J.

Vaccine. 2013 Nov 22;31 Suppl 8:I53-7. doi: 10.1016/j.vaccine.2013.06.107. Review.

PMID:
24229720
3.

"HPV? Never heard of it!": a systematic review of girls' and parents' information needs, views and preferences about human papillomavirus vaccination.

Hendry M, Lewis R, Clements A, Damery S, Wilkinson C.

Vaccine. 2013 Oct 25;31(45):5152-67. doi: 10.1016/j.vaccine.2013.08.091. Epub 2013 Sep 9. Review.

PMID:
24029117
4.

Overcoming the barriers to HPV vaccination in high-risk populations in the US.

Downs LS Jr, Scarinci I, Einstein MH, Collins Y, Flowers L.

Gynecol Oncol. 2010 Jun;117(3):486-90. doi: 10.1016/j.ygyno.2010.02.011. Epub 2010 Mar 29. Review.

PMID:
20303156
5.

Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis.

Ferrer HB, Trotter C, Hickman M, Audrey S.

BMC Public Health. 2014 Jul 9;14:700. doi: 10.1186/1471-2458-14-700. Review.

6.

Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.

Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S.

JAMA Pediatr. 2014 Jan;168(1):76-82. doi: 10.1001/jamapediatrics.2013.2752. Review.

7.

Human papillomavirus vaccination in adolescence.

Russell M, Raheja V, Jaiyesimi R.

Perspect Public Health. 2013 Nov;133(6):320-4. doi: 10.1177/1757913913499091. Epub 2013 Sep 4. Review.

PMID:
24006173
8.

Cervical cancer prevention: new tools and old barriers.

Scarinci IC, Garcia FA, Kobetz E, Partridge EE, Brandt HM, Bell MC, Dignan M, Ma GX, Daye JL, Castle PE.

Cancer. 2010 Jun 1;116(11):2531-42. doi: 10.1002/cncr.25065. Review.

9.

Applying a gender lens on human papillomavirus infection: cervical cancer screening, HPV DNA testing, and HPV vaccination.

Branković I, Verdonk P, Klinge I.

Int J Equity Health. 2013 Feb 8;12:14. doi: 10.1186/1475-9276-12-14. Review.

10.

Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review.

Perlman S, Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG.

PLoS One. 2014 Mar 11;9(3):e90912. doi: 10.1371/journal.pone.0090912. eCollection 2014. Review.

11.

Human Papillomavirus Infection and Vaccination.

Valentino K, Poronsky CB.

J Pediatr Nurs. 2016 Mar-Apr;31(2):e155-66. doi: 10.1016/j.pedn.2015.10.005. Epub 2015 Nov 14. Review.

PMID:
26586310
12.

How does public policy impact cervical screening and vaccination strategies?

Herzog TJ, Huh WK, Einstein MH.

Gynecol Oncol. 2010 Nov;119(2):175-80. doi: 10.1016/j.ygyno.2010.08.021. Review.

13.

Parental acceptance and uptake of the HPV vaccine among African-Americans and Latinos in the United States: A literature review.

Galbraith KV, Lechuga J, Jenerette CM, Moore LA, Palmer MH, Hamilton JB.

Soc Sci Med. 2016 Jun;159:116-26. doi: 10.1016/j.socscimed.2016.04.028. Epub 2016 Apr 30. Review.

PMID:
27180256
14.

Social media microblogs as an HPV vaccination forum.

Zhang C, Gotsis M, Jordan-Marsh M.

Hum Vaccin Immunother. 2013 Nov;9(11):2483-9. Epub 2013 Jul 10. Review.

15.

Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence.

Katz IT, Ware NC, Gray G, Haberer JE, Mellins CA, Bangsberg DR.

Sex Health. 2010 Sep;7(3):279-86. doi: 10.1071/SH09130. Review.

16.

HPV vaccine acceptability among men: a systematic review and meta-analysis.

Newman PA, Logie CH, Doukas N, Asakura K.

Sex Transm Infect. 2013 Nov;89(7):568-74. doi: 10.1136/sextrans-2012-050980. Epub 2013 Jul 4. Review.

17.

What school nurses need to know about cervical cancer, HPV, and the new vaccine.

Ehrhardt J.

J Sch Nurs. 2007 Dec;23(6):310-4. Review.

PMID:
18052515
18.

Underutilization of cervical cancer prevention services in low and middle income countries: a review of contributing factors.

Chidyaonga-Maseko F, Chirwa ML, Muula AS.

Pan Afr Med J. 2015 Jul 30;21:231. doi: 10.11604/pamj.2015.21.231.6350. eCollection 2015. Review.

19.

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.

Brotherton JM, Jit M, Gravitt PE, Brisson M, Kreimer AR, Pai SI, Fakhry C, Monsonego J, Franceschi S.

Int J Cancer. 2016 Aug 1;139(3):510-7. doi: 10.1002/ijc.30063. Epub 2016 Mar 22. Review.

20.

Innovations in HPV vaccination and roles of nurses in cervical cancer prevention.

Yildirim JG, Arabaci Z.

Asian Pac J Cancer Prev. 2014;15(23):10053-6. Review.

Supplemental Content

Support Center